- EXOGENIS For Clinics & Partners
Bring regenerative skin delivery
into everyday clinical practice
Designed for dermatology and aesthetic clinics, ExoGenis complements existing post-procedure protocols with a controlled regenerative skin delivery step between treatment sessions.
Seamless Workflow Integration
Designed to fit after selected procedures such as laser, RF, micro needling, peels, or other clinic-led skin treatments.
Clinic-Guided Care
Support structured between-treatement care and clinic-guided maintenance.
real-World Validation
Pilot use will test workflow fit, repeat use, behaviour, reorder intent, and clinic economics.
Clinic-Guided Care Pathway
A structured approach to integrating regenerative skin delivery into real clinical practice.
01. IN CLINIC
Designed to complement selected dermatology and aesthetic procedures as part of the clinic's post-procedure protocol.
02. AT HOME
.webp)
Patients follow a clinic-defined regenerative care protocol between visits, according to guidance from their healthcare professional.
03. FOLLOW UP
Pilot partners provide feedback on usability, workflow integration, patient experience and protocol implementation to support future product development.
Designed for clinical validation
The ExoGenis pilot programme helps clinics evaluate how regenerative skin delivery fits into existing treatment workflows while generating early clinical and usability insights.
Clinical pilot package
Illustrative pilot economics
.svg)
100
eligible patients / month
.svg)
.svg)
30 %
pilot adoption assumption
.svg)
€100–150
indicative price per application
llustrative gross revenue opportunity
€3,000 – €4,500 / month
Based on sample adoption and pricing assumptions.
Actual use, pricing, and margins to be validated.
More than a patch: a structured, clinic-guided approach to validating regenerative skin delivery in real clinical practice
- Why Partner With ExoGenis
Help shape the future
of regenerative skin delivery
We're working with a small group of forward-thinking dermatology and aesthetic clinics to validate the next generation of clinic-guided biologic delivery.
Early Clinical Innovation
Participate in early product validation and help shape future treatment protocols.
Clinic Workflow Integration
Evaluate how the platform fits into existing post-procedure workflows and patient pathways.
Clinical Feedback & Co-Development
Work directly with the ExoGenis team to refine product design, protocols and clinical use cases.
Future Partnership Opportunities
Early partners will have priority access to future pilot programmes, commercial collaborations and new product developments.
- 2026 Co-Creation Partnership
Shaping the future of regenerative skin
delivery
We are selecting 3-5 clinics to co-develop, validate and refine the next generation of regenerative skin delivery protocols
Month 0
01
Clinical planning & protocol design
Month 1
02
controlledpilot deployment
Month 2
03
Pilot implementation
Month 3
04
Clinical feedbacks & next-step planning
pilot partners will help evaluate usability, workflow integration and early clinical experience to shape future product development
- protocol
ExoGenis maintenance protocol
Designed for clinic deployment and structured pilot testing.
When it’s used
- Post-procedure (laser, RF, injectables)
- Between treatment sessions
- Ongoing maintenance programs
How it’s sold
- 4–12 treatment programs
- Add-on or standalone
- Continuation of clinical results
Why it works commercially
- Designed for recurring usage per patient
- No additional chair time
- Fits existing workflows
- 4–12 applications per treatment cycle
- 2026 Launch
Is your clinic a good fit?
We're looking for forward-thinking clinics that share our commitment to innovation and patient care excellence.
- Perform injectable or device-based treatments
- Work with biologic actives (exosomes, peptides, growth factors)
- Want structured maintenance protocols
- Value clinical differentiation
Designed to add a new clinic-guided delivery and aftercare layer
Integrates seamlessly into existing clinic workflows
Extends the clinical toolkit without replacing injectables or devices.
Extends and enhances treatment outcomes between visits
Supports maintenance, recovery, and biologic support between major procedures.
Supports care between visits
Designed for post-procedure skincare support, maintenance protocols, and clinic-guided care between appointments.
High-margin recurring revenue stream
Revenue depends on protocol design, pricing, and patient adoption - validated during pilot phase.
- LIMITED EARLY ACCESS
Partnership application
ExoGenis is currently onboarding a limited number of clinics and strategic partners for early collaboration, validation dialogue, and future commercial access.
We are especially interested in dermatology, regenerative aesthetics, and biologic-focused clinical workflows.
*Developed in collaboration with clinical, academic, and biologic delivery partners including DTU and international validation collaborators.